Abstract
Purpose
Teleconsultation is a consultation between two or more physicians about the diagnostic work-up and therapeutic strategy in the treatment of an individual case by means of modern telematics. ‘Drip-and-ship’ teleconsultation model consists of the transfer of patients, through telematics stroke networks, with large arteries occlusions from primary to comprehensive stroke centers equipped for endovascular therapy. We retrospectively investigated appropriateness, safety, and effectiveness of ‘drip-and-ship’ teleconsultation model in a rural area of Tuscany.
Methods
Outcome measures were: door-to-ship time (including door-to-needle time), ratio of number treated/total sent patients, adverse events/mortality during transfer, and mortality and modified Rankin scale at 90 days. Analysis of non-treated patients was also done.
Results
Seventy-eight patients were included; 16/78 patients were sent for endovascular therapy alone, and 62/78 for “drip-and-ship”; 12 patients were not treated. Door-to-ship, and door-to-needle times (mean ± SD) were 105 ± 29.8 and 62.5 ± 37.5 min, respectively. The ratio number of treated/total sent patients was 0.85. At 90 days, the global mortality rate was 21%, and 40% of patients showed favorable outcome. The main cause of non-treatment was spontaneous recanalization.
Conclusions
The high value for treated/total sent patients’ ratio underlines that “drip-and-ship” teleconsultation model is appropriate and effective, with a few untreated patients. The model is safe, without adverse events during transfer. Taken together, our outcomes are in line with the previous reports. “Drip-and-ship” teleconsultation model is safe and effective in rural areas, allowing good selections and rapid treatments for stroke patients, based on the transfer from the primary to the comprehensive stroke center.
References
Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, Lima F, Rosenthal ES, Rost N, Viswanathan A, Schwamm LH (2010) Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 41(1):e18–e24. https://doi.org/10.1161/STROKEAHA.109.560169
Feussner H, Etter M, Siewert JR (1998) Teleconsultation. Chirurg 69(11):1129–1133
Wechsler LR, Demaerschalk BM, Schwamm LH, Adeoye OM, Audebert HJ, Fanale CV, Hess DC, Majersik JJ, Nystrom KV, Reeves MJ, Rosamond WD, Switzer JA, American Heart Association Stroke Council; Council on Epidemiology and Prevention; Council on Quality of Care and Outcomes Research (2017) Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(1):e3–e25. https://doi.org/10.1161/STR.0000000000000114
Nardetto L, Dario C, Tonello S, Brunelli MC, Lisiero M, Carraro MG, Saccavini C, Scannapieco G, Giometto B (2016) A one-to-one telestroke network: the first Italian study of a web-based telemedicine system for thrombolysis delivery and patient monitoring. Neurol Sci 37(5):725–730. https://doi.org/10.1007/s10072-016-2569-y
Richard S, Lavandier K, Zioueche Y, Pelletier S, Vezain A, Ducrocq X (2014) Use of telemedicine to manage severe ischaemic strokes in a rural area with an elderly population. Neurol Sci 35(5):683–685. https://doi.org/10.1007/s10072-013-1577-4
Timpano F, Bonanno L, Bramanti A, Pirrotta F, Spadaro L, Bramanti P, Lanzafame P (2013) Tele-health and neurology: what is possible? Neurol Sci 34(12):2263–2270. https://doi.org/10.1007/s10072-012-1285-5
Milne MS, Holodinsky JK, Hill MD, Nygren A, Qiu C, Goyal M, Kamal N (2017) Drip ‘n ship versus mothership for endovascular treatment: modeling the best transportation options for optimal outcomes. Stroke 48(3):791–794. https://doi.org/10.1161/STROKEAHA.116.015321
Bonita R, Beaglehole R (1988) Modification of Rankin scale: recovery of motor function after stroke. Stroke 19(12):1497–1500
Ipek E, Oktay AA, Krim SR (2017) Hypertensive crisis: an update on clinical approach and management. Curr Opin Cardiol 32(4):397–406. https://doi.org/10.1097/HCO.0000000000000398
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviot SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123(23):2736–2747. https://doi.org/10.1161/CIRCULATIONAHA.110.009449
Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi CR, Rodrigues E, Zhao H, Salvaris P, Garcia-Esperon C, Bailey P, Rice H, de Vilers L, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Wong AA, Muller C, Coulthard A, Mitchell K, Clouston J, Mahady K, Field D, Ma H, Phan TG, Chong W, Chandra RV, Slater LA, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM, EXTEND-IA TNK Investigators (2018) Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 378(17):1573–1582. https://doi.org/10.1056/NEJMoa1716405
Ishihara H, Oka F, Oku T, Shinoyama M, Suehiro E, Sugimoto K, Suzuki M (2017) Safety and time course of drip-and-ship in treatment of acute ischemic stroke. J Stroke Cerebrovasc Dis 26(11):2477–2481. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.008
Li BH, Ding X, Yin YW, Liu Y, Gao CY, Zhang LL, Li JC (2013) Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3-4.5 hours. Curr Med Res Opin 29(9):1105–1114. https://doi.org/10.1185/03007995.2013.818533
Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigator (2017) Association between onset-to-door time and clinical outcomes after ischemic stroke. Stroke 48(11):3049–3056. doi: https://doi.org/10.1161/STROKEAHA.117.018132
Bernetti L, Nuzzaco G, Muscia F, Gamboni A, Zedde M, Eusebi P, Zampolini M, Corea F (2018) Stroke networks and telemedicine: an Italian national survey. Neurol Int 10(1):7599. https://doi.org/10.4081/ni.2018.7599
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 97 kb)
Rights and permissions
About this article
Cite this article
Gallerini, S., Marsili, L., Groccia, V. et al. Appropriateness, safety, and effectiveness of “drip and ship” teleconsultation model in Southeastern Tuscany: a feasibility study. Neurol Sci 41, 2961–2965 (2020). https://doi.org/10.1007/s10072-020-04446-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04446-x